Multiple Myeloma Treatment Cost in India
Compare cost by treatment approach, understand your options, and get a free personalised estimate from India's accredited cancer centres within 48 hours.
Top Hospitals
for Multiple Myeloma Treatment
Find accredited cancer centres with dedicated hematology-oncology units and stem cell transplant facilities.
Explore Hospitals →Top Doctors
for Multiple Myeloma Treatment
Connect with internationally trained hematologists specialising in plasma cell disorders and myeloma care.
Find Doctors →The multiple myeloma treatment cost in India ranges from $6,000 to $40,000. Standard chemotherapy and supportive care (non-transplant) costs $6,000-$12,000, treatment including an autologous stem cell transplant costs $17,000-$30,000, and relapsed cases needing advanced targeted or CAR T-cell therapy can reach $40,000-$60,000.
Multiple Myeloma Treatment Cost in India — Overview
The multiple myeloma treatment cost in India typically ranges from $6,000 to $40,000, making India one of the most affordable destinations globally for this blood cancer. The exact multiple myeloma treatment cost in India depends on whether treatment is chemotherapy-based, includes an autologous stem cell transplant, or involves advanced targeted therapy for relapsed disease.
Multiple myeloma is a cancer of plasma cells — the white blood cells responsible for producing antibodies — that develops in the bone marrow. India's leading cancer centres combine JCI/NABH accreditation with experienced hematologist-oncologists and dedicated stem cell transplant units, helping international patients access advanced myeloma care at a fraction of Western costs.
| Treatment Information | Details |
|---|---|
| Condition | Multiple Myeloma (Plasma Cell Cancer) |
| Treatment Name | Chemotherapy, Targeted Therapy, or Autologous Stem Cell Transplant |
| Duration | 4-6 Months (Induction to Maintenance) |
| Treated By | Hematologist-Oncologist |
What Is Multiple Myeloma?
Multiple myeloma is a blood cancer that begins in plasma cells — white blood cells made in the bone marrow that normally produce antibodies to fight infection. In multiple myeloma, abnormal plasma cells multiply uncontrollably in the bone marrow, crowding out normal blood cell production and producing a non-functional protein (M-protein) instead of healthy antibodies, which leaves the immune system weaker and more prone to infection.
Common symptoms include bone pain (especially in the back or ribs, affecting around 70% of patients), fatigue and anemia, frequent infections, kidney problems, and high blood calcium levels that can cause thirst, confusion, or constipation. Diagnosis typically involves blood and urine tests, a bone marrow biopsy, and imaging such as X-ray, MRI, or CT scans.
What Are the Signs and Symptoms of Multiple Myeloma?
- Bone pain — the most common symptom, especially in the back, ribs, and hips, as cancerous plasma cells weaken bone
- Fatigue and weakness — caused by anemia (low red blood cell count)
- Frequent infections — due to reduced normal antibody production
- Bone fractures — even minor impact can cause fractures as bones become weakened
- High calcium levels (hypercalcemia) — bone breakdown releases calcium into the blood, causing excessive thirst, confusion, constipation, or nausea
- Kidney problems — abnormal proteins can damage the kidneys, leading to weakness and swelling
- Unexplained weight loss
- Numbness or weakness in the legs — if spinal bones are affected and press on nearby nerves
Many patients have no symptoms in the early stages, and multiple myeloma is sometimes discovered through routine blood tests before symptoms appear.
Multiple Myeloma Treatment Cost in India by Treatment Type
| Treatment Approach | Approx. Cost (USD) |
|---|---|
| Chemotherapy & Supportive Care (Non-Transplant) | $6,000 – $12,000 |
| Treatment with Autologous Stem Cell Transplant | $17,000 – $30,000 |
| Relapsed/Refractory (Advanced Targeted / CAR T-Cell Therapy) | $40,000 – $60,000 |
*Figures are indicative starting estimates. Your exact multiple myeloma treatment cost in India depends on your case — request a personalised quote after sharing your reports.
How Is Multiple Myeloma Treated?
- Chemotherapy — combination drug regimens to reduce cancerous plasma cells
- Targeted therapy — proteasome inhibitors and immunomodulatory drugs that specifically attack myeloma cells
- Corticosteroids — used alongside other treatments to enhance effectiveness
- Autologous stem cell transplant — the patient's own stem cells are collected, treatment intensified, then cells reinfused to deepen remission
- Maintenance therapy — ongoing lower-dose treatment after initial response to extend remission
- Supportive care — bone-strengthening medication and management of complications like anemia or kidney issues
Is a Stem Cell Transplant Always Needed?
No. Many multiple myeloma patients are managed effectively with chemotherapy, targeted therapy, and supportive care alone. An autologous stem cell transplant is typically considered for eligible patients — generally those who are younger and fit enough for the intensive conditioning process — to deepen and extend remission. Your hematologist will assess eligibility based on age, overall health, and response to initial treatment.
Why the Multiple Myeloma Treatment Cost in India Is Lower
Multiple myeloma treatment in the US typically starts from $150,000, and private care in the UK can range from $65,000 to $130,000. The multiple myeloma treatment cost in India remains a fraction of these figures while using the same drug classes and transplant technology available internationally.
Choosing India for multiple myeloma treatment means combining major cost savings with access to internationally trained hematologists at accredited cancer centres.
Multiple Myeloma Treatment Cost: India vs Other Countries
| Country | Chemotherapy + Supportive Care | Autologous Stem Cell Transplant (ASCT) | Targeted Therapy (per month) | CAR T-Cell Therapy |
|---|---|---|---|---|
| United States | $70,000 – $120,000 | $120,000 – $250,000 | $10,000 – $20,000 | $400,000 – $500,000 |
| United Kingdom | $60,000 – $100,000 | $90,000 – $180,000 | $8,000 – $15,000 | Not widely available |
| UAE | $40,000 – $80,000 | $80,000 – $150,000 | $6,000 – $12,000 | $300,000 – $400,000 |
| India | $6,000 – $12,000 | $15,000 – $30,000 | $1,200 – $3,000 | $40,000 – $60,000 |
Key Observations:
- India offers the lowest cost across every treatment category compared to the US, UK, and UAE
- Chemotherapy and supportive care in India costs roughly 85-90% less than in the US
- An autologous stem cell transplant costs $15,000-$30,000 in India vs. up to $250,000 in the US
- Monthly targeted therapy is significantly cheaper in India, easing the burden of extended maintenance treatment
- CAR T-cell therapy, while still expensive, is available in India at roughly one-eighth the cost of the US and is not widely available in the UK at all
Factors Affecting the Multiple Myeloma Treatment Cost in India
- Treatment approach — chemotherapy alone vs. stem cell transplant vs. advanced targeted therapy
- Stage at diagnosis — earlier-stage disease may need less intensive treatment
- Number of treatment cycles — response to therapy determines cycle count
- Hospital and city — accreditation level and local operating costs
- Diagnostic tests — bone marrow biopsy, imaging, and blood work
- Complications — kidney issues or infections can extend treatment and cost
Outlook and Survival
Multiple myeloma is generally not considered curable but is treatable and often manageable as a chronic condition. Survival outcomes depend heavily on stage at diagnosis, genetic risk factors, and response to treatment. According to the Leukemia & Lymphoma Society, ongoing advances in targeted therapy and transplant approaches have significantly extended survival and quality of life for many myeloma patients in recent years.
Key Outcome Indicators in India
- On average, patients treated in India see overall survival somewhere between 5 and 10 years, though this varies widely based on disease stage at diagnosis, the treatment protocol followed, and individual factors such as age and other existing health conditions
- The length of time patients stay in remission without disease progression has improved meaningfully with modern triplet drug combinations and post-transplant maintenance regimens
- Among patients eligible for an autologous stem cell transplant, complete remission is achieved in roughly 60-70% of cases in India — broadly in line with outcomes reported internationally — with many going on to enjoy extended disease-free periods
- Larger, high-volume treatment centres tend to report stronger outcomes overall, helped by access to advanced diagnostics, robust infection-control practices, and close post-treatment follow-up
- Even patients with higher-risk genetic markers are seeing improved results as Indian cancer centres adopt monoclonal antibodies and newer-generation therapies
Survival Outlook by Risk Category
- Patients classified as standard-risk generally have a 5-year survival rate in the range of 70-80% when treatment (including transplant, where appropriate) begins promptly
- Patients in the high-risk category typically see somewhat lower 5-year survival figures, often 40-60%, although outcomes continue to improve as newer treatment options become available
- Those diagnosed with smoldering multiple myeloma may not need active treatment right away and can remain stable for years, provided they're monitored closely by their care team
How Azzocare Helps International Patients
Azzocare connects international patients with verified hematologists and JCI-accredited cancer centres across Delhi NCR, managing every step at no extra cost:
- Free medical opinion and itemised cost estimate within 48 hours of sharing your reports
- Medical visa documentation and travel planning support
- Airport pickup and accommodation arranged near your hospital
- Interpreter support throughout consultations and admission
- A dedicated case manager from first contact through follow-up care
Whether you're comparing the multiple myeloma treatment cost in India across hospitals or ready to start your treatment plan, our care team can shortlist the right hospital and hematologist for your case before you travel.
Frequently Asked Questions
What is the multiple myeloma treatment cost in India?
The multiple myeloma treatment cost in India typically ranges from $6,000 to $40,000, depending on whether treatment is chemotherapy-based, includes an autologous stem cell transplant, or requires advanced targeted therapy for relapsed cases.
Does multiple myeloma treatment always require a stem cell transplant?
No. Many patients are managed with chemotherapy, targeted therapy, and supportive care alone. An autologous stem cell transplant is considered for eligible patients, typically those who are younger and fit enough for the intensive conditioning process.
What is included in the multiple myeloma treatment cost in India?
Standard packages include hematologist consultation, diagnostic tests (blood work, imaging, bone marrow biopsy), medication or chemotherapy cycles, hospital stay if needed, and routine monitoring. Stem cell transplant, if required, is usually quoted as a separate package.
How is multiple myeloma treated in India?
Treatment typically combines chemotherapy, targeted therapy (such as proteasome inhibitors or immunomodulatory drugs), corticosteroids, and supportive care for bone health. Eligible patients may also undergo autologous stem cell transplant to deepen and extend remission.
What is the cost of a stem cell transplant for multiple myeloma?
An autologous stem cell transplant for multiple myeloma typically costs $17,000 to $30,000 in India, including the conditioning chemotherapy, cell collection, transplant procedure, and hospital stay.
Can I get a cost estimate before travelling to India for multiple myeloma treatment?
Yes. Share your diagnosis, blood test results, and imaging reports with Azzocare's care team, and our hematology panel sends a free, itemised cost estimate — usually within 48 hours.
What is the survival rate for multiple myeloma treatment in India?
Survival outcomes depend heavily on stage at diagnosis, response to treatment, and patient health, but many patients diagnosed early and treated with modern combination therapy live for many years with the disease well controlled.
How long does multiple myeloma treatment take?
Initial induction therapy typically spans 4-6 months. If a stem cell transplant is planned, expect an additional 3-4 weeks for the transplant phase, followed by maintenance therapy that can continue for an extended period.
Is multiple myeloma curable?
Multiple myeloma is generally not considered curable, but it is treatable and often manageable as a chronic condition. Many patients achieve long periods of remission with modern combination therapies and maintenance treatment.
How long do international patients need to stay in India for multiple myeloma treatment?
This depends on your treatment plan — chemotherapy-only patients may need shorter periodic visits, while stem cell transplant patients typically stay 5-6 weeks to cover conditioning, the transplant, and initial recovery.
What treatment options exist for relapsed multiple myeloma?
Relapsed or refractory cases may be treated with newer targeted therapies, monoclonal antibodies, or CAR T-cell therapy in specialised centres, generally at a higher cost than first-line treatment.
Does Azzocare charge for arranging multiple myeloma treatment in India?
No. All of Azzocare's services — medical opinion, cost estimate, visa assistance, airport pickup, and case coordination — are completely free for patients. You only pay the hospital's standard treatment cost.
What Our Patients Say
Real experiences from patients treated for multiple myeloma through Azzocare.
My father's myeloma was managed with targeted therapy alone, no transplant needed. The hematologist reviewed his response every cycle and adjusted the plan carefully.
The stem cell transplant package matched exactly what was quoted, no hidden fees. Six weeks in India and I came home with counts recovering well.
We were worried about relapse after treatment abroad failed. The advanced targeted therapy option here gave us a new path forward that we hadn't been offered before.
Bone pain from myeloma was managed alongside the main treatment — the supportive care plan made a real difference to daily comfort during chemotherapy cycles.
Comparing costs against the US made this decision easy for our family. Same drug classes, verified hospital, at a price we could actually afford long-term.
Fourteen months into maintenance therapy and doing well. The case manager still checks in periodically, which means more than I expected it to.